NE

Healthcare · Pharmaceuticals

Nectar Lifescience Ltd (NECLIFE)

₹9.81

Mkt cap
₹200 Cr
P/E ratio
—
P/B
0.33
Div yield
0.00%
ROE
−31.30%
ROCE
0.05%
EPS (TTM)
—
Book value
₹29
52W range
9–22
Sector
Healthcare

Price history

Previous close

Incorporated in 1995, Nectar Lifesciences Ltd manufactures APIs and Formulations [1]

NSE NECLIFEBSE 532649
Health check
Cautious
ProfitabilityWeak
GrowthLow
TechnicalsBearish
52-week range
−56.21% from high
₹10
₹9+5.48% from low₹22
Current
₹9.81
Prev close
₹9.98
Day
−1.70%
Price performance
1D
−1.70%
1W
−7.97%
1M
−8.83%
3M
−4.66%
6M
−19.66%
1Y
−33.49%
YTD
−51.24%

Financials

Revenue, profit & margin
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales397.97452.17441.38359.305.740.010.015.240.710.001.290.440.01
YoY Sales growth+2.40%+31.40%+13.52%-8.84%-98.56%-100.00%-100.00%-98.54%-87.63%-100.00%+12,800.00%-91.60%-98.59%
Expenses371.11409.98392.88319.496.330.060.066.080.161.9358.5327.716.69
Operating Profit26.8642.1948.5039.81-0.59-0.05-0.05-0.840.55-1.93-57.24-27.27-6.68
OPM %6.75%9.33%10.99%11.08%-10.28%-500.00%-500.00%-16.03%77.46%-4,437.21%-6,197.73%-66,800.00%
Other Income10.610.481.470.556.528.08-129.80-62.23-176.2835.46-24.423.2413.22
Interest20.5224.8424.1619.980.000.000.000.000.0030.225.900.160.00
Depreciation15.3115.3714.7015.460.450.070.300.530.110.060.080.110.11
Profit before tax1.642.4611.114.925.487.96-130.15-63.60-175.843.25-87.64-24.306.43
Tax %38.41%36.18%94.69%39.63%-2.19%1.51%-0.05%-0.58%0.09%-339.08%-22.50%-36.63%57.70%
Net Profit1.021.570.592.975.607.84-130.09-63.23-176.0114.27-67.92-15.402.72
EPS in Rs0.050.070.030.130.250.35-5.80-2.82-7.850.64-3.50-0.790.14
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +2.09% · closed higher next day 0 of last 1
 Q1FY27
Broadcast14 Aug '26◦
Earnings day+2.09%
+1 day−2.18%
+5 days−2.55%
+15 days+9.73%
+30 days−2.64%
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
51.84%Promoter
Promoters51.84%
FIIs0.50%
DIIs0.00%0.01
Public43.74%0.16
Government3.92%0.17
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,867.5036.424,48,0760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,080.0086.072,94,1390.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,691.2082.191,78,4380.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,220.0089.521,19,9490.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,192.0026.241,18,9020.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,377.9041.111,15,0920.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,394.5036.281,12,6600.93%852−35.05%7,404−2.44%15.49%
Nectar Lifesci.₹10.31—2000.00%3+1,086.67%0−98.59%0.05%
Median: 160 Co.₹449.5033.402,0180.08%13+33.73%179+21.23%14.94%

Filings